Is it wise to eliminate lymphography from the staging of Hodgkin's disease?

被引:4
作者
Guermazi, A [1 ]
机构
[1] St Louis Univ Hosp, Dept Radiol, F-75013 Paris, France
关键词
lymphography; staging; Hodgkin's disease; lymphoma;
D O I
10.3109/10428190109099326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We believe that lymphography and CT are complementary rather than mutually exclusive techniques for the diagnosis and staging of HD. Unfortunately, it seems that many radiologists and clinicians disregard the ability of lymphography to provide qualitative information on lymph node architecture, which is not available by CT. The use of lymphography is declining in several teaching centers throughout the world. This makes it difficult for young radiologists to acquire the skills needed to perform and interpret lymphographies successfully. In turn. radiologists who have little experience with lymphography are less likely to use the technique. Because most of the treatment-related morbidity in HD is dose-related, and because lymphography helps to avoid over- and undertreatment, we believe that high-quality lymphography continues to have a significant role in the staging of selected HD patients. Moreover, lymphography may reduce both the cost of management and the morbidity rate in many HD patients. One solution would be to continue to use lymphography in a small number of institutions specialized in the management of HD.
引用
收藏
页码:655 / 660
页数:6
相关论文
共 50 条
  • [1] Staging of Hodgkin's disease
    Trumper, L
    Hartmann, F
    Kranzhofer, N
    Pfreundschuh, M
    TUMORDIAGNOSTIK & THERAPIE, 1996, 17 (05) : 154 - 157
  • [2] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Schiepers, Christiaan
    Filmont, Jean-Emmanuel
    Czernin, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S82 - S88
  • [3] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [4] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41
  • [5] Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Vinnicombe, Sarah J.
    Reznek, Rodney H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S42 - S55
  • [6] Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Sarah J. Vinnicombe
    Rodney H. Reznek
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S42 - S55
  • [7] Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease
    Munker, R
    Glass, J
    Griffeth, LK
    Sattar, T
    Zamani, R
    Heldmann, M
    Shi, R
    Lilien, DL
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1699 - 1704
  • [8] Role of bone marrow examination in staging Hodgkin's disease:: experience in Mexico
    Gómez-Almaguer, D
    Ruiz-Argüelles, GJ
    López-Martínez, B
    Estrada, E
    Lobato-Mendizábal, E
    Jaime-Pérez, JC
    CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (04): : 221 - 223
  • [9] Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease
    VandenAnkerLugtenburg, PJ
    Krenning, EP
    Oei, HY
    VanHagen, MP
    Gerrits, CJH
    Reubi, JC
    Lamberts, SWJ
    Lowenberg, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) : 96 - 103
  • [10] Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma
    Hoh, CK
    Glaspy, J
    Rosen, P
    Dahlbom, M
    Lee, SJ
    Kunkel, L
    Hawkin, RA
    Maddahi, J
    Phelps, ME
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (03) : 343 - 348